Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.198 | -53.5135135135 | 0.37 | 0.3833 | 0.141 | 8493236 | 0.27241294 | CS |
4 | -0.231 | -57.3200992556 | 0.403 | 0.407 | 0.141 | 2441879 | 0.27947937 | CS |
12 | -0.134 | -43.7908496732 | 0.306 | 0.6559 | 0.141 | 7081973 | 0.52687203 | CS |
26 | -4.418 | -96.2527233115 | 4.59 | 4.9979 | 0.141 | 3750476 | 0.59801938 | CS |
52 | -14.0004 | -98.7863735147 | 14.1724 | 21.56 | 0.141 | 2117296 | 1.68858499 | CS |
156 | -748.708 | -99.9770323683 | 748.88 | 971.5156 | 0.141 | 1124363 | 195.71965544 | CS |
260 | -30.0164 | -99.4302447298 | 30.1884 | 2640 | 0.141 | 870221 | 272.51983539 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.